Thanks Lundbeck! What a joke - how about explaining exactly how you scrub the data and why our scripts don't ever match up with our partners? How about explaining the rationale for continuing to sell Rexulti to that patient who is between 64 and 65 yet you don't pay your reps on those? How about having a better data set that actually has prescribers where there actually are? I guess you are too cheap to pay for the data although you still hold the reps responsible? How about explaining WHY the payout grids are different instead of attempting to justify why they exist? And why do aplha reps get split credit but not beta or gamma? Fair - I think not. Takeda reps all get paid on split credit and you know there are many more reps over there. Transparent I think not.
LOL reading the threads it looks like Lundbeck people aren't worried about HOW they get paid but IF they get paid. Looks like the company gamble was not a success